Scholarly article on topic 'P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO'

P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO Academic research paper on "Veterinary science"

0
0
Share paper
Academic journal
Pediatr Rheumatol
OECD Field of science
Keywords
{""}

Academic research paper on topic "P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO"

Kostik et al. Pediatric Rheumatology 2013, 11(Suppl 1):A201 http://www.ped-rheum.com/content/11/S1/A201

t % PEDIATRIC

RHEUMATOLOGY

MEETING ABSTRACT

Open Access

P03-006 - Pamidronate rapidly decreases CRP and TNF A in CNO

MM Kostik1*, LI Vasyakina2, VM Ponomarenko2, IA Chikova1, AV Minkin3, OV Kalashnikova1, IV Shvedovchenko3, VG Chasnyk1

From 7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID) Lausanne, Switerland. 22-26 May 2013

Introduction

Pediatric chronic nonbacterial osteomyelitis (CNO) is a sterile inflammatory bone disorder of presumed autoimmune or autoinflammatory etiology. Sometimes CNO associated with other rheumatologic conditions, such spondylarthritis, sacroileitis, IBD, pyoderma gangreno-sum and psoriasis as well as a part of distinct autoinflam-matory disease (AID), such as DIRA syndrome.

Case report

14 year old girl was admitted to our department with pain, low and moderate grade fever, delay to thrive and history of osteomyelitis. Her family history was unremarkable. The onset of disease was in the age of 10 months with small bone lesion in distal epiphysis of femur and intensive irritability. After 1 month of immobilization she had an intensive bone overgrowth with periostal reaction and deformity in distal epiphysis. The bone biopsy confirmed non-specific osteomyelitis, malignancy and infection was excluded. Antibiotic treatment was ineffective. Her disease had wide-spread course involving the whole femur from distal to proximal part. The main features included bone lesions, bone overgrowth, intensive periostal reaction and sclerosis. The disease had persistant course without remission episodes, accompanied with pain, irritability, fever and lead to elongation of femur (+8 cm). She had failure to thrive since the age of 6 years. Currently she looks like as 8 year old girl in her 14 years. Intellectual development is normal. No signs of any other diseases, particularly recurrent infections and involvement of other bones. A Tc99m bone scan revealed increased uptake only in the whole femur (+400%). Laboratorial features were specific for AID: persisted microcytic anemia (Hb-8.0 gr/dl),

1HospitalPediatry, Saint-Petersburg State Pediatric MedicalUniversity, Saint-

Petersburg, Russian Federation

Full list of author information is available at the end of the article

ESR>110 mm\h (n.v.<15), CRP >150 mg/l (n.v.<5), sidero-penia. Immunological assessment was detected increased Ig A (5.2 gr\l), Ig G (26.2 gr\l) and decreased zymozan-induced chemoluminescence (11 Units, lower limit -160). Chronic granulomatose disease (CGD) was confirmed without any known foci of serious infection during her life. Also high levels of IL1p, IL-6 and TNFa were detected. NSAIDs appeared short temporary effect.

In our clinic we started to treat her with pamidronate 1,5 mg/kg on 1 cycle, with monthly repeated courses. After first cycle the CRP was decreased from 150 to 19 mg/l, ESR from 58 to 12 mm\h, TNFa from 169 to 19 pg\ml. Hb increased up to 10.2 gr/dl. No pain, irritability and fever after initiating pamidronate therapy.

Discussion

We describe a case of early presented chronic nonbacterial osteomyelytis affected of only one bone. Early onset (first year of life), permanent progredient course, systemic features (fever, failure to thrive), typical laboratorial changes (microcytic anemia, very high ESR and CRP), increased levels of IL1p, IL-6 and TNFa are characteristic for AID. The described case can be new form of an AID with clinical features resembling CRMO or DIRA diseases. Biologics can be considered to be a promising way of further treatment as it has been reported to be successful already for small number of cases.

Competing interests

None Declared.

Authors' details

1HospitalPediatry, Saint-Petersburg State Pediatric MedicalUniversity, Saint-Petersburg, Russian Federation. 2Department of Immunology, Federal Institute of Public Health, The Nikiforov's Russian Center of Emergency and Radiation Medicine, Saint-Petersburg, Russian Federation. 3St. Petersburg Scientific and Practical Center of Medical and Social Expertise, Prosthetics and Rehabilitation n.a. G.A. Albrecht, Saint-Petersburg, Russian Federation.

© 2013 Kostik et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons CGntfäl Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Kostik et al. Pediatric Rheumatology 2013, 11 (Suppl 1):A201 Page 2 of 2

http://www.ped-rheum.com/content/11/S1/A201

Published: 8 November 2013

doi:10.1186/1546-0096-11-S1-A201

Cite this article as: Kostik et al.: P03-006 - Pamidronate rapidly decreases CRP and TNFA in CNO. Pediatric Rheumatology 2013 11 (Suppl 1):A201.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at fpntral

www.biomedcentral.com/submit v_enudi